Year |
Citation |
Score |
2014 |
Briehl MM, Tome ME, Wilkinson ST, Jaramillo MC, Lee K. Mitochondria and redox homoeostasis as chemotherapeutic targets. Biochemical Society Transactions. 42: 939-44. PMID 25109983 DOI: 10.1042/Bst20140087 |
0.544 |
|
2012 |
Wilkinson ST, Tome ME, Briehl MM. Mitochondrial adaptations to oxidative stress confer resistance to apoptosis in lymphoma cells. International Journal of Molecular Sciences. 13: 10212-28. PMID 22949856 DOI: 10.3390/Ijms130810212 |
0.65 |
|
2012 |
Schmelz M, Montes-Moreno S, Piris M, Wilkinson ST, Rimsza LM. Lack and/or aberrant localization of major histocompatibility class II (MHCII) protein in plasmablastic lymphoma. Haematologica. 97: 1614-6. PMID 22689685 DOI: 10.3324/Haematol.2011.060186 |
0.394 |
|
2012 |
Wilkinson ST, Vanpatten KA, Fernandez DR, Brunhoeber P, Garsha KE, Glinsmann-Gibson BJ, Grogan TM, Teruya-Feldstein J, Rimsza LM. Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma. Blood. 119: 1459-67. PMID 22167754 DOI: 10.1182/Blood-2011-07-363820 |
0.358 |
|
2011 |
Schmelz M, Montes-Moreno S, Piris M, Wilkinson ST, Rimsza LM. Lack of Major Histocompatibility Class II (MHCII) Protein and Decreased Immunosurveillance in Plasmablastic Lymphoma (PBL) Blood. 118: 5186-5186. DOI: 10.1182/Blood.V118.21.5186.5186 |
0.399 |
|
2010 |
Wilkinson ST, Johnson DB, Tardif HL, Tome ME, Briehl MM. Increased cytochrome c correlates with poor survival in aggressive lymphoma. Oncology Letters. 1: 227-230. PMID 20798784 DOI: 10.3892/Ol_00000040 |
0.653 |
|
2010 |
Stasik CJ, Nitta H, Zhang W, Mosher CH, Cook JR, Tubbs RR, Unger JM, Brooks TA, Persky DO, Wilkinson ST, Grogan TM, Rimsza LM. Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma. Haematologica. 95: 597-603. PMID 20378577 DOI: 10.3324/Haematol.2009.012864 |
0.363 |
|
2010 |
Wilkinson ST, Fernandez DR, Vanpatten KA, Glinsmann-Gibson BJ, Grogan TM, Rimsza LM. Abstract 1769: Loss of major histocompatibility class II expression in diffuse large B-cell lymphoma may be related to stage of B-cell differentiation Cancer Research. 70: 1769-1769. DOI: 10.1158/1538-7445.Am10-1769 |
0.427 |
|
2009 |
Wilkinson ST, Fernandez DR, Murphy SP, Braziel RM, Campo E, Chan WC, Delabie J, Gascoyne RD, Staudt LM, Jaffe ES, Rosenwald A, Rimsza LM. Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV. Leukemia & Lymphoma. 50: 1875-8. PMID 19814686 DOI: 10.3109/10428190903297531 |
0.422 |
|
2009 |
James BP, Staatz WD, Wilkinson ST, Meuillet E, Powis G. Superoxide dismutase is regulated by LAMMER kinase in Drosophila and human cells. Free Radical Biology & Medicine. 46: 821-7. PMID 19135146 DOI: 10.1016/J.Freeradbiomed.2008.12.012 |
0.328 |
|
2009 |
Wilkinson ST, Bob R, Stein H, Schwartz M, Braziel RM, Gascoyne RD, Rimsza LM. A Comparison of Gene Expression Pattern in Major Histocompatibility Class II-Low Diffuse Large B-Cell Lymphoma with Plasmablastic Lymphoma. Blood. 114: 1941-1941. DOI: 10.1182/Blood.V114.22.1941.1941 |
0.404 |
|
Show low-probability matches. |